Osiris Therapeutics (OSIR) Tops Q3 EPS Views by 10c
Tweet Send to a FriendGet Alerts OSIR Hot Sheet
Price: $10.65 --0%
EPS Growth %: -100.0%
Financial Fact:
Income before income taxes: -2.74M
Today's EPS Names:
ATU, CRWS, CLC, More
EPS Growth %: -100.0%
Financial Fact:
Income before income taxes: -2.74M
Today's EPS Names:
ATU, CRWS, CLC, More
Trade OSIR Now!
Osiris Therapeutics, Inc. (Nasdaq: OSIR) reports Q3 EPS of $0.14, 10 cents better than the consensus of $0.04. Revenue for the quarter came in at $10.8 million, compared to the consensus of $10.47 million.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Fedex Corp. (FDX) Tops Q4 EPS by 17c, Sales Light
- La-Z-boy, Inc. (LZB) Tops Q4 EPS by 5c
- American Superconductor (AMSC) Reports In-Line Q4 EPS; Guides Q1
Create E-mail Alert Related Categories
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
